Join to access to all OVN content. Join for Free

Fuel Progress

Dive into the collective wisdom, insights, and strategies from experts in pharma and biotech.

Start Exploring

Medical Voice Network
Medical Voice Network

Trending on OVN

01

OVN Avatar OVN Staff
Visionaries Behind Oncology Voice Network: Dr. Ramin Farhood & Dr. Kirk Shepard

May 12th • 5 mins read

02

OVN Avatar OVN Staff
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes

May 25th • 5 mins read

03

OVN Avatar OVN Staff
Introducing OncologyVoiceNetwork.com

May 1st • 8 mins read

04

OVN Avatar B. Gyawali, E. G. E. de Vries, U. Dafni, T. Amaral, J. Barriuso, J. Bogaerts, A. Calles, G. Curigliano, C. Gomez-Roca, B. Kiesewetter, S. Oosting, A. Passaro, G. Pentheroudakis, M. Piccart, F. Roitberg, J. Tabernero, N. Tarazona, D. Trapani, R. Wester, G.
Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring

Apr 20th • 8 mins read

05

OVN Avatar A. Haslam, M.S. Kim, V. Prasad
Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020

Apr 20th • 7 mins read

06

Partner Avatar Envision Pharma Group
AI-powered real-world evidence: Strategically enhancing value and access

Aug 22nd • 5 mins read


Featured Articles

virtual-oncology-msl-team-increases-kol-engagement-by-120
Partner Avatar iNIZIO
Virtual Oncology MSL Team Increases KOL Engagement by 120%

Sep 3rd • 1 min read

clinical-educator-oncology-program-improves-adherence-by-29
Partner Avatar iNIZIO
Clinical Educator Oncology Program Improves Adherence by 29%​

Sep 3rd • 1 min read

transforming-oncology-five-frontiers-driving-progress-in-cancer-care
Partner Avatar iNIZIO
Transforming oncology: Five frontiers driving progress in cancer care

May 16th • 5 mins read

expert-perspectives-live-from-asco-2025
Partner Avatar iNIZIO
Expert perspectives live from ASCO® 2025

Jul 2nd • 1 min read

evaluation-of-trials-comparing-singleenantiomer-drugs-to-their-racemic-precursors-a-systematic-review
OVN Avatar Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

May 6th • 18 mins read


Blog
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes

We are proud to announce the forthcoming publication of Voices of Oncology — a first-of-its-kind collection of expert perspectives from across the oncology ecosystem, arriving July 2025 in partnership with...

Blog
Visionaries Behind Oncology Voice Network: Dr. Ramin Farhood & Dr. Kirk Shepard
Visionaries Behind Oncology Voice Network: Dr. Ramin Farhood & Dr. Kirk Shepard

At the heart of the Oncology Voice Network (OVN) is a powerful mission: to unify oncology leaders across disciplines and accelerate the development of solutions that truly serve patients. Driving...

Blog
Introducing OncologyVoiceNetwork.com
Introducing OncologyVoiceNetwork.com

A New Era of Insight, Collaboration, and Innovation in Oncology

We are proud to announce the official launch of OncologyVoiceNetwork.com — a next-generation media platform purpose-built to serve the evolving needs...